W.l.gore & Associates
Clinical trials sponsored by W.l.gore & Associates, explained in plain language.
-
New eye implant could help glaucoma patients cut medication
Disease control OngoingThis study tests a new device called the GORE Glaucoma Drainage Implant in 30 adults with open-angle glaucoma that is not controlled by eye drops or where standard surgery might fail due to scarring. The implant is placed in the eye to help drain fluid and lower eye pressure. The…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Apr 28, 2026 13:47 UTC
-
New heart valve device offers hope for patients with congenital defects
Disease control OngoingThis study is testing a new device called the GORE PV1 to replace the pulmonary valve and fix the right ventricular outflow tract in people with congenital heart defects like Tetralogy of Fallot. The study includes 15 participants aged 5 and older. The main goal is to see if the …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
Heart hole plug tested to stop strokes
Disease control OngoingThis study looks at a device that plugs a small hole in the heart (called PFO) to help prevent strokes in people who have had a stroke with no clear cause. About 300 people in Japan will be followed for a year to see if the device closes the hole safely and reduces stroke risk. T…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC